Skip to main content

Next generation in-blood glucose monitoring using non-invasive optoacoustic sensing

Objective

"GLUMON aims to leverage a new class of a biomedical optoacoustic sensor developed under the FETOpen project RSENSE (GA #862811) and offer the next generation of non-invasive biochemical in-vivo sensing. The preliminary sensor for non-invasive in-blood glucose sensing has already produced outstanding findings and places the technology well ahead of its competition. Addressing the limitations of existing sensors, mainly accurate non-invasive continuous monitoring of blood-glucose as well as comfort, the GLUMON sensor will better address diabetes healthcare needs. As a secondary goal and contingency plan, GLUMON will exploit this technology as a lipid sensor and build further potential by addressing the emerging precision nutrition market.
The objectives of the GLUMON project are to:
1) mature the technology from a lab bench-top setup to a functional portable sensor prototype;
2) improve its market readiness level;
3) validate and demonstrate the sensor in the lab as well as in preclinical and clinical settings;
4) develop a sound business case and exploitation strategy; and
5) address regulatory and ethical requirements for this medical device in preparation for the next phase.
The GLUMON consortium includes the key developers of the technology, two SMEs for prototyping, quality control and tech-to-market transition, and two university clinical partners for sensor validation. Key stakeholders (type-2 diabetes patients, patient advocacy groups, clinicians, health insurance) will be involved during the project to assess user needs and market requirements. Overall, the GLUMON sensor has the potential to play a critical role in future medicine by improving diabetes management and, more generally, by promoting new healthcare concepts in obesity and metabolic diseases, including early disease detection and home-based disease monitoring.
"

Coordinator

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Net EU contribution
€ 852 978,00
Address
Ingolstadter Landstrasse 1
85764 Neuherberg
Germany

See on map

Region
Bayern Oberbayern München, Landkreis
Activity type
Research Organisations
Other funding
€ 852 978,00

Participants (4)

STHESIS GMBH
Germany
Net EU contribution
€ 560 732,00
Address
Gautinger Strasse 27 F
82234 Wessling

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Bayern Oberbayern Starnberg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 560 732,00
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN
Germany
Net EU contribution
€ 309 625,00
Address
Ismaninger Strasse 22
81675 Muenchen

See on map

Region
Bayern Oberbayern München, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Other funding
€ 309 625,00
MEDIZINISCHE UNIVERSITAT GRAZ
Austria
Net EU contribution
€ 320 875,00
Address
Neue Stiftingtalstrasse 6
8010 Graz

See on map

Region
Südösterreich Steiermark Graz
Activity type
Higher or Secondary Education Establishments
Other funding
€ 320 875,00
ALIRA HEALTH SL
Spain
Net EU contribution
€ 150 000,00
Address
Av Josep Tarradellas 132 Planta 7
08029 Barcelona

See on map

Region
Este Cataluña Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 150 000,00

Partners (1)

RAYFOS LTD
United Kingdom
Net EU contribution
€ 0,00
Address
Winton House Winton Square
RG21 8EN Basingstoke

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
South East (England) Hampshire and Isle of Wight North Hampshire
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
No data